Report
Martial Descoutures

Nouvelle commande aux US - NEUTRE - OC 3,6€ (vs 3,2€)

La société a annoncé l’enregistrement d’une nouvelle commande de 1m$ aux US portant le carnet de commandes à 3m$ sur la zone depuis 8 mois. Il s’agit du même partenaire californien que lors de la précédente commande de 2m$ enregistrée au T1 17. Spineway signe un départ intéressant sur le plus gros marché du monde. Nous conservons notre estimation de 7,6m€ en 2017e. L’actualisons des paramètres de marché et de notre valorisation par les Comparables entraine un relèvement de notre objectif à 3,6€ (vs 3,2€). Nous maintenons notre recommandation NEUTRE.
Underlying
Spineway SAS

Spineway SA, formerly known as Spineway SAS is a France-based company involved in medical products manufacturing. It designs, produces and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, among others.

Provider
Invest Securities
Invest Securities

Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.

Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.

Analysts
Martial Descoutures

Other Reports on these Companies
Other Reports from Invest Securities
Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli
Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli
Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli

ResearchPool Subscriptions

Get the most out of your insights

Get in touch